Interactions between nanoparticles and lymphatic systems: Mechanisms and applications in drug delivery

被引:13
作者
Tang, Yisi [1 ,2 ,3 ,4 ]
Liu, Bao [1 ,2 ]
Zhang, Yuting [1 ,2 ]
Liu, Yuling [1 ,2 ]
Huang, Yongzhuo [1 ,5 ,6 ,7 ]
Fan, Wufa [1 ,2 ]
机构
[1] Chinese Acad Med Sci & Peking Union Med Coll, State Key Lab Bioact Subst & Funct Nat Med, Inst Mat Med, Beijing 100050, Peoples R China
[2] Chinese Acad Med Sci & Peking Union Med Coll, Inst Mat Med, Beijing Key Lab Drug Delivery Technol & Novel Form, Beijing 100050, Peoples R China
[3] Chinese Acad Med Sci, Inst Lab Anim Sci, NHC Key Lab Comparat Med, Natl Ctr Technol Innovat Anim Model, Beijing 100021, Peoples R China
[4] Peking Union Med Coll, Comparat Med Ctr, Beijing 100021, Peoples R China
[5] Chinese Acad Sci, Shanghai Inst Mat Med, State Key Lab Drug Res, Shanghai 201203, Peoples R China
[6] Chinese Acad Sci, Zhongshan Inst Drug Discovery, Shanghai Inst Mat Med, Zhongshan 528437, Peoples R China
[7] NMPA Key Lab Qual Res & Evaluat Pharmaceut Excipie, Shanghai 201203, Peoples R China
基金
中国国家自然科学基金;
关键词
Lymphatic system; Lymphatic delivery system; Lymph node; Protein corona; Dendritic cell; Vaccine; LIPID-BASED FORMULATIONS; DENDRITIC CELLS; SUBCUTANEOUS INJECTION; ORAL DELIVERY; TRANSPORT; NODE; ACID; ABSORPTION; LIPOSOMES; EXPOSURE;
D O I
10.1016/j.addr.2024.115304
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
The lymphatic system has garnered significant attention in drug delivery research due to the advantages it offers, such as enhancing systemic exposure and enabling lymph node targeting for nanomedicines via the lymphatic delivery route. The journey of drug carriers involves transport from the administration site to the lymphatic vessels, traversing the lymph before entering the bloodstream or targeting specific lymph nodes. However, the anatomical and physiological barriers of the lymphatic system play a pivotal role in influencing the behavior and efficiency of carriers. To expedite research and subsequent clinical translation, this review begins by introducing the composition and classification of the lymphatic system. Subsequently, we explore the routes and mechanisms through which nanoparticles enter lymphatic vessels and lymph nodes. The review further delves into the interactions between nanomedicine and body fluids at the administration site or within lymphatic vessels. Finally, we provide a comprehensive overview of recent advancements in lymphatic delivery systems, addressing the challenges and opportunities inherent in current systems for delivering macromolecules and vaccines.
引用
收藏
页数:20
相关论文
共 173 条
  • [1] Lymphatic targeting by albumin-hitchhiking: Applications and optimisation
    Abdallah, Mohammad
    Mullertz, Olivia O.
    Styles, Ian K.
    Morsdorf, Alexander
    Quinn, John F.
    Whittaker, Michael R.
    Trevaskis, Natalie L.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2020, 327 : 117 - 128
  • [2] Molecular engineering solutions for therapeutic peptide delivery
    Acar, Handan
    Ting, Jeffrey M.
    Srivastava, Samanvaya
    LaBelle, James L.
    Tirrell, Matthew V.
    [J]. CHEMICAL SOCIETY REVIEWS, 2017, 46 (21) : 6553 - 6569
  • [3] The biomolecular gastrointestinal corona in oral drug delivery
    Aljabbari, Anas
    Kihara, Shinji
    Rades, Thomas
    Boyd, Ben J.
    [J]. JOURNAL OF CONTROLLED RELEASE, 2023, 363 : 536 - 549
  • [4] Antigen Targeting of Porcine Skin DEC205+ Dendritic Cells
    Alonso Melgoza-Gonzalez, Edgar
    Resendiz-Sandoval, Monica
    Hinojosa-Trujillo, Diana
    Hernandez-Valenzuela, Sofia
    Garcia-Vega, Melissa
    Mata-Haro, Veronica
    Tepale-Segura, Araceli
    Bonifaz, Laura C.
    Perez-Torres, Armando
    Hernandez, Jesus
    [J]. VACCINES, 2022, 10 (05)
  • [5] I.p.-injected cationic liposomes are retained and accumulate in peritoneally disseminated tumors
    Ando-Matsuoka, Rie
    Ando, Hidenori
    Abu Lila, Amr S.
    Maeda, Noriyuki
    Shimizu, Taro
    Ishima, Yu
    Ishida, Tatsuhiro
    [J]. JOURNAL OF CONTROLLED RELEASE, 2022, 341 : 524 - 532
  • [6] Targeted Delivery of Immunomodulators to Lymph Nodes
    Azzi, Jamil
    Yin, Qian
    Uehara, Mayuko
    Ohori, Shunsuke
    Tang, Li
    Cai, Kaimin
    Ichimura, Takaharu
    McGrath, Martina
    Maarouf, Omar
    Kefaloyianni, Eirini
    Loughhead, Scott
    Petr, Jarolim
    Sun, Qidi
    Kwon, Mincheol
    Tullius, Stefan
    von Andrian, Ulrich H.
    Cheng, Jianjun
    Abdi, Reza
    [J]. CELL REPORTS, 2016, 15 (06): : 1202 - 1213
  • [7] Targeted delivery of immune therapeutics to lymph nodes prolongs cardiac allograft survival
    Bahmani, Baharak
    Uehara, Mayuko
    Jiang, Liwei
    Ordikhani, Farideh
    Banouni, Naima
    Ichimura, Takaharu
    Solhjou, Zhabiz
    Furtmuller, Georg J.
    Brandacher, Gerald
    Alvarez, David
    von Andrian, Ulrich H.
    Uchimura, Kenji
    Xu, Qiaobing
    Vohra, Ishaan
    Yilmam, Osman A.
    Haik, Yousef
    Azzi, Jamil
    Kasinath, Vivek
    Bromberg, Jonathan S.
    McGrath, Martina M.
    Abdi, Reza
    [J]. JOURNAL OF CLINICAL INVESTIGATION, 2018, 128 (11) : 4770 - 4786
  • [8] Functionally specialized junctions between endothelial cells of lymphatic vessels
    Baluk, Peter
    Fuxe, Jonas
    Hashizume, Hiroya
    Romano, Talia
    Lashnits, Erin
    Butz, Stefan
    Vestweber, Dietmar
    Corada, Monica
    Molendini, Cinzia
    Dejana, Elisabetta
    McDonald, Donald M.
    [J]. JOURNAL OF EXPERIMENTAL MEDICINE, 2007, 204 (10) : 2349 - 2362
  • [9] The clinical progress of mRNA vaccines and immunotherapies
    Barbier, Ann J.
    Jiang, Allen Yujie
    Zhang, Peng
    Wooster, Richard
    Anderson, Daniel G.
    [J]. NATURE BIOTECHNOLOGY, 2022, 40 (06) : 840 - 854
  • [10] Bile acid transporter-mediated oral absorption of insulin via hydrophobic ion-pairing approach
    Bashyal, Santosh
    Seo, Jo-Eun
    Choi, Young Wook
    Lee, Sangkil
    [J]. JOURNAL OF CONTROLLED RELEASE, 2021, 338 : 644 - 661